BOS 0.00% 1.5¢ biosignal limited

It's the therapeutic angle which most interests me. It appears...

  1. 160 Posts.
    It's the therapeutic angle which most interests me. It appears to be a slam-dunk based on strong experimental results to date.

    But there are so many applications that this can't stay independent for long. My minimum expectation is $5 per share in a takeover.
 
watchlist Created with Sketch. Add BOS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.